Table 6.
Comparison between insufficient LND and sufficient LND in patients with any risky comorbidity
| Insufficient LND | Sufficient LND | |||
|---|---|---|---|---|
| n = 42 | n = 107 | |||
| n (%) | n (%) | p | ||
| Age | ≥75 | 18 (43) | 45 (42) | 0.93 |
| <75 | 24 (57) | 62 (58) | ||
| Gender | male | 34 (81) | 76 (71) | 0.22 |
| female | 8 (19) | 34 (29) | ||
| Tumor stage | I | 22 (52) | 96 (90) | <0.001 |
| II | 14 (33) | 7 (7) | ||
| III | 6 (14) | 4 (4) | ||
| LND | D1 | 2 (5) | 1 (0.9) | 0.015 |
| D1+ | 40 (95) | 91 (85) | ||
| D2 | 0 (0) | 15 (14) | ||
| No. of risky comorbidity | 1 | 32 (76) | 83 (78) | 0.73 |
| 2 | 9 (21) | 19 (18) | ||
| ≥3 | 1 (2) | 5 (5) | ||
| All PCs | 12 (29) | 32 (30) | 0.87 | |
| Abdominal PCs | 8 (19) | 27 (25) | 0.42 | |
| Non-abdominal PCs | 9 (21) | 9 (8) | 0.028 | |